Global private equity and venture capital news and research

Carlyle invests in Sunsho Pharmaceutical from third Japanese fund

24 Jun 2014

fujiyamaPrivate equity major Carlyle has bought Japanese health and nutrition (H&N) and pharmaceutical products maker Sunsho Pharmaceutical.

The Shizuoka-based company operates five factories, which are focused on contract manufacturing and packaging services of soft capsules, seamless capsules and other dosage forms for H&N and pharmaceutical use.

Carlyle will make the investment from its Japan Partners III fund, which is targeting JPY100bn ($980m), which is below the JPY165.6bn raised by its second Japanese vehicle in 2006.

In January this year it was reported that Carlyle had secured JPY45bn ($436m) for the fund.

Carlyle managing director Takaomi Tomioka said, “Sunsho Pharmaceutical has established a solid position as a contract manufacturer in the steadily growing H&N market in Japan.

“With its competitive edge in R&D and manufacturing capabilities, the company is poised for continued growth.

“We were impressed by Sunsho Pharmaceutical’s competitive positioning and growth potential, and have a strong appreciation of its management philosophy and culture.”

Meanwhile, Carlyle is reportedly in talks to buy Japanese snack maker Oyatsu for more than $250m.

Copyright © 2014 AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016